Group items tagged

The Toronto Region Immigrant Employment Council (TRIEC) is pleased to announce today's appointment of Gordon M. Nixon, president and chief executive officer of RBC, as Chair, and Zabeen Hirji, chief human resources officer of RBC, as Co-Chair of TRIEC.

As top executives at one of the largest financial institutions in North America, Gord Nixon and Zabeen Hirji are key ambassadors to articulate how Canadian companies can benefit from the international experience and networks, language skills and cultural knowledge that skilled immigrants bring with them to Canada."

Nixon has for years been a champion for promoting diversity in Canadian communities and of leveraging skilled immigrant talent as a driver of Canadian innovation and prosperity. Nixon is chairman of the Canadian Council of Chief Executives and chairman of MaRS Discovery District. In 2007, Nixon was invested into the Order of Ontario and was named Canada's Outstanding CEO of the Year.

The event will mark the official opening of the new WORLDiscoveries office at MaRS.   WORLDiscoveries is a joint business development consortium formed between Western, Robarts and Lawson Health Research Institute to bridge local inventions and global industry.  

The MaRS Discovery District is a non-profit innovation centre that connects science, technology and entrepreneurs with business skills, networks and capital to stimulate innovation and accelerate the growth of successful Canadian enterprise

: Collaboration Room 2 MaRS Centre 101 College Street Toronto, Ontario

Dr. David Williams, Ontario's acting medical officer of health announced the cases during a press conference downtown at the Mars Centre.

Dr. David Williams, Ontario's acting medical officer of health announced the cases during a press conference downtown at the Mars Centre.

Canada has always had to fight hard to attract talent and investment

MaRS Vital to Toronto's life sciences vision is MaRS (derived from Medical and Related Sciences) a non-profit organisation and business centre located in the heart of the city. Its core function is as a biotech incubator and business park, known as MaRS Discovery District. The venture was first established in 2000 to help foster and accelerate the growth of successful Canadian businesses and, after some uncertain times, it is now gathering momentum. A separate technology transfer office, MaRS Innovation, has also been established that, it is hoped, can be a world beater in its own right (see Turning good ideas into world beaters below). The location of the MaRS building in central Toronto is important, as it is just a stone's throw away from an existing cluster of universities and academic hospitals. MaRS has many links with other research-based organisations, including collaborations with three local universities, 10 academic teaching hospitals and the Ontario Institute for Cancer Research. MaRS occupies the Old Toronto general hospital, where insulin was first discovered by Best and Banting in 1921 and then developed for use in human trials. The 21st Century organisation can build on this heritage in patient-focused discovery and development. Formerly the head of venture capital firm Primaxis, Ilse Treurnicht is chief executive of MaRS Discovery District. She acknowledges the crisis in venture capital funding, and says Canada's sector has always had less access funds through this route than other countries. This is one of the drivers behind the search for a new approach. Treurnicht says the old models of building biotech and life sciences businesses have to be discarded, as they have failed to build companies with critical mass. She says MaRS' new 'Convergence Innovation' strategy of bringing science, capital and business together will pay off.

"We call our strategy 'Convergence Innovation' and what we are trying to do is move away from the old linear model of academics struggling in their spare time to build companies or entrepreneurs doing this in a very incremental way."It takes time and it has many risk points along the way. So using this Convergence centre model to create a much more dynamic organisation which can help accelerate good ideas towards the commercialisation." But she says Canada's geography and demographics are always going to be a challenge. "This is a very large country with a small population. If you think in terms of clusters and hub regions, Canada's business hubs are separated geographically, and there is not much in between in terms of people."That means we can't try to be a little United States, because we just won't show up on the radar. We have to take a different approach. We have to think about collaboration as our potential competitive advantage - that means using networks and associations to solve problems and build businesses."So as new opportunities emerge, we can take them to market faster and hopefully with a higher success rate." The centre currently accommodates numerous start up companies, as well as those providing legal and financial services to them. AstraZeneca and GlaxoSmithKline also have offices on site. In all, MaRS provides mentoring for over 200 different companies across Ontario, and runs courses on entrepreneurship and preparing products for market.

MaRS is particularly honoured to be the administrator of the Premier’s Summit Award for Medical Research, one of the largest research prizes in Canada, and recognizing truly exceptional world leading accomplishments. Every Canadian should be proud that these pioneering science leaders live and work in Ontario.

MaRs Centre CR-3 101 College Street Toronto

Dr. David Williams, Ontario's Chief Medical Officer of Health, will be providing an update on the province's surveillance for H1N1 flu virus.